We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:2064H
GW Pharmaceuticals PLC
07 February 2003
GW Pharmaceuticals plc ("the Company")
Warrant exercise and application to AIM
Pursuant to the exercise by Adrian Bradshaw of a warrant over 217,500 new
ordinary shares of 0.1p each in the Company ("New Ordinary Shares") at a price
of 60p per share, the Company has today issued and allotted the New Ordinary
Shares and applied for them to be admitted to the Alternative Investment Market
of the London Sotck Exchange. Such admission is expected to become effective on
Wednesday 12 February 2003.
7th February 2003
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUUUBAPUPWGUM
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
